Loading…

Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls

Sub-Saharan Africa concentrates the largest burden of cervical cancer worldwide. The introduction of the HPV vaccination in this region is urgent and strategic to meet global health targets. This was a cross-sectional study conducted in Mozambique prior to the first round of the HPV vaccine demonstr...

Full description

Saved in:
Bibliographic Details
Published in:Papillomavirus research 2018-06, Vol.5, p.156-162
Main Authors: Bardají, Azucena, Mindu, Carolina, Augusto, Orvalho J., Casellas, Aina, Cambaco, Olga, Simbine, Egas, Matsinhe, Graça, Macete, Eusébio, Menéndez, Clara, Sevene, Esperança, Munguambe, Khátia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c559t-249c8d506d54441bba7c7004fba65f826b0ba9421cfebfb02dd4c83e02b24ea3
cites cdi_FETCH-LOGICAL-c559t-249c8d506d54441bba7c7004fba65f826b0ba9421cfebfb02dd4c83e02b24ea3
container_end_page 162
container_issue
container_start_page 156
container_title Papillomavirus research
container_volume 5
creator Bardají, Azucena
Mindu, Carolina
Augusto, Orvalho J.
Casellas, Aina
Cambaco, Olga
Simbine, Egas
Matsinhe, Graça
Macete, Eusébio
Menéndez, Clara
Sevene, Esperança
Munguambe, Khátia
description Sub-Saharan Africa concentrates the largest burden of cervical cancer worldwide. The introduction of the HPV vaccination in this region is urgent and strategic to meet global health targets. This was a cross-sectional study conducted in Mozambique prior to the first round of the HPV vaccine demonstration programme. It targeted girls aged 10–19 years old identified from schools and households. Face-to-face structured interviews were conducted. A total of 1147 adolescents were enrolled in three selected districts of the country. Most girls [84% (967/1147)] had heard of cervical cancer, while 76% believed that cervical cancer could be prevented. However only 33% (373/1144) of girls recognized having ever heard of HPV. When girls were asked whether they would accept to be vaccinated if a vaccine was available in Mozambique, 91% (1025/1130) answered positively. Girls from the HPV demonstration districts showed higher awareness on HPV and cervical cancer, and willingness to be vaccinated. This study anticipates high acceptability of the HPV vaccine in Mozambique and high awareness about cervical cancer, despite low HPV knowledge. These results highlight that targeted health education programmes are critical for acceptance of new tools, and are encouraging for the reduction of cervical cancer related mortality and morbidity in Mozambique. •Cervical cancer incidence rates in Mozambique are among the highest in the world.•Introduction of HPV vaccination in Mozambique is an urgent and necessary strategy to meet global targets on women´s health.•The awareness on cervical cancer, and anticipated acceptance of HPV vaccination was assessed in Mozambican adolescent girls.•The study anticipates high acceptability of HPV vaccine and adequate awareness about cervical cancer.•These results are timely in the context towards the implementation of the HPV vaccine at a national scale in Mozambique.
doi_str_mv 10.1016/j.pvr.2018.04.004
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4a6b5788d6344280bd85e06d9e11d656</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S240585211730085X</els_id><doaj_id>oai_doaj_org_article_4a6b5788d6344280bd85e06d9e11d656</doaj_id><sourcerecordid>2027066617</sourcerecordid><originalsourceid>FETCH-LOGICAL-c559t-249c8d506d54441bba7c7004fba65f826b0ba9421cfebfb02dd4c83e02b24ea3</originalsourceid><addsrcrecordid>eNp9kk1v3CAQhq2qVROl-QG9VBx72S1gwLYqVYqifkRK1UvuaIDxhsiGLdiO0l9fdjddbS49IL7eeYZ5map6z-iaUaY-Pay3S1pzyto1FWtKxavqnAsqV63k7PXJ-qy6zPmBUspkLTsm31ZnvFNKipqeV09Xj5AwYM4k9sRiWryFgVgIZU0gOPLoh8GHzV4yRWKQLGCtDzChI7ABH_JE7ucRAtnCtojjCItPcyY-kJ_xD4ymIAMBFwfMFsNENj4N-V31poch4-XzfFHdfft6d_1jdfvr-8311e3KStlNKy462zpJlZNCCGYMNLYp1fYGlOxbrgw10AnObI-mN5Q7J2xbI-WGC4T6oro5YF2EB71NfoT0pCN4vT-IaaMhTd4OqAUoI5u2daoWgrfUuFZiSdwhY05JVVhfDqztbEZ0u1oSDC-gL2-Cv9ebuGhFhVKtKAB2ANg8W52weGxh2gceN7vBacN1TRuldkk_PidN8feMedKjLzYOAwSMcy5a3tAiZM0JPsWcE_bHpzGqd02jiwNL0rum0VToYmOJ-XBa0zHiX4sUweeDAMsnLR6TztZjaQ_ny5unYqP_D_4v8OfVAA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2027066617</pqid></control><display><type>article</type><title>Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls</title><source>ScienceDirect (Online service)</source><source>PubMed Central</source><creator>Bardají, Azucena ; Mindu, Carolina ; Augusto, Orvalho J. ; Casellas, Aina ; Cambaco, Olga ; Simbine, Egas ; Matsinhe, Graça ; Macete, Eusébio ; Menéndez, Clara ; Sevene, Esperança ; Munguambe, Khátia</creator><creatorcontrib>Bardají, Azucena ; Mindu, Carolina ; Augusto, Orvalho J. ; Casellas, Aina ; Cambaco, Olga ; Simbine, Egas ; Matsinhe, Graça ; Macete, Eusébio ; Menéndez, Clara ; Sevene, Esperança ; Munguambe, Khátia</creatorcontrib><description>Sub-Saharan Africa concentrates the largest burden of cervical cancer worldwide. The introduction of the HPV vaccination in this region is urgent and strategic to meet global health targets. This was a cross-sectional study conducted in Mozambique prior to the first round of the HPV vaccine demonstration programme. It targeted girls aged 10–19 years old identified from schools and households. Face-to-face structured interviews were conducted. A total of 1147 adolescents were enrolled in three selected districts of the country. Most girls [84% (967/1147)] had heard of cervical cancer, while 76% believed that cervical cancer could be prevented. However only 33% (373/1144) of girls recognized having ever heard of HPV. When girls were asked whether they would accept to be vaccinated if a vaccine was available in Mozambique, 91% (1025/1130) answered positively. Girls from the HPV demonstration districts showed higher awareness on HPV and cervical cancer, and willingness to be vaccinated. This study anticipates high acceptability of the HPV vaccine in Mozambique and high awareness about cervical cancer, despite low HPV knowledge. These results highlight that targeted health education programmes are critical for acceptance of new tools, and are encouraging for the reduction of cervical cancer related mortality and morbidity in Mozambique. •Cervical cancer incidence rates in Mozambique are among the highest in the world.•Introduction of HPV vaccination in Mozambique is an urgent and necessary strategy to meet global targets on women´s health.•The awareness on cervical cancer, and anticipated acceptance of HPV vaccination was assessed in Mozambican adolescent girls.•The study anticipates high acceptability of HPV vaccine and adequate awareness about cervical cancer.•These results are timely in the context towards the implementation of the HPV vaccine at a national scale in Mozambique.</description><identifier>ISSN: 2405-8521</identifier><identifier>EISSN: 2405-8521</identifier><identifier>DOI: 10.1016/j.pvr.2018.04.004</identifier><identifier>PMID: 29665430</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject><![CDATA[Adolescent ; Adult ; Awareness and acceptability ; Cervical cancer ; Cervix cancer ; Child ; Cross-Sectional Studies ; Càncer de coll uterí ; Female ; Health Education - statistics & numerical data ; Health Knowledge, Attitudes, Practice ; Human papillomavirus ; Humans ; Immunization Programs ; Mozambique ; Papillomaviridae - isolation & purification ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines - administration & dosage ; Papillomaviruses ; Papil·lomavirus ; Patient Acceptance of Health Care ; Surveys and Questionnaires ; Uterine Cervical Neoplasms - prevention & control ; Uterine Cervical Neoplasms - virology ; Vaccination - statistics & numerical data ; Vaccine ; Young Adult]]></subject><ispartof>Papillomavirus research, 2018-06, Vol.5, p.156-162</ispartof><rights>2018 The Authors</rights><rights>Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>cc by-nc-nd (c) Elsevier, 2018 info:eu-repo/semantics/openAccess &lt;a href="http://creativecommons.org/licenses/by-nc-nd/3.0/es/"&gt;http://creativecommons.org/licenses/by-nc-nd/3.0/es/&lt;/a&gt;</rights><rights>2018 The Authors. Published by Elsevier B.V. 2018</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c559t-249c8d506d54441bba7c7004fba65f826b0ba9421cfebfb02dd4c83e02b24ea3</citedby><cites>FETCH-LOGICAL-c559t-249c8d506d54441bba7c7004fba65f826b0ba9421cfebfb02dd4c83e02b24ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046684/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S240585211730085X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29665430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bardají, Azucena</creatorcontrib><creatorcontrib>Mindu, Carolina</creatorcontrib><creatorcontrib>Augusto, Orvalho J.</creatorcontrib><creatorcontrib>Casellas, Aina</creatorcontrib><creatorcontrib>Cambaco, Olga</creatorcontrib><creatorcontrib>Simbine, Egas</creatorcontrib><creatorcontrib>Matsinhe, Graça</creatorcontrib><creatorcontrib>Macete, Eusébio</creatorcontrib><creatorcontrib>Menéndez, Clara</creatorcontrib><creatorcontrib>Sevene, Esperança</creatorcontrib><creatorcontrib>Munguambe, Khátia</creatorcontrib><title>Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls</title><title>Papillomavirus research</title><addtitle>Papillomavirus Res</addtitle><description>Sub-Saharan Africa concentrates the largest burden of cervical cancer worldwide. The introduction of the HPV vaccination in this region is urgent and strategic to meet global health targets. This was a cross-sectional study conducted in Mozambique prior to the first round of the HPV vaccine demonstration programme. It targeted girls aged 10–19 years old identified from schools and households. Face-to-face structured interviews were conducted. A total of 1147 adolescents were enrolled in three selected districts of the country. Most girls [84% (967/1147)] had heard of cervical cancer, while 76% believed that cervical cancer could be prevented. However only 33% (373/1144) of girls recognized having ever heard of HPV. When girls were asked whether they would accept to be vaccinated if a vaccine was available in Mozambique, 91% (1025/1130) answered positively. Girls from the HPV demonstration districts showed higher awareness on HPV and cervical cancer, and willingness to be vaccinated. This study anticipates high acceptability of the HPV vaccine in Mozambique and high awareness about cervical cancer, despite low HPV knowledge. These results highlight that targeted health education programmes are critical for acceptance of new tools, and are encouraging for the reduction of cervical cancer related mortality and morbidity in Mozambique. •Cervical cancer incidence rates in Mozambique are among the highest in the world.•Introduction of HPV vaccination in Mozambique is an urgent and necessary strategy to meet global targets on women´s health.•The awareness on cervical cancer, and anticipated acceptance of HPV vaccination was assessed in Mozambican adolescent girls.•The study anticipates high acceptability of HPV vaccine and adequate awareness about cervical cancer.•These results are timely in the context towards the implementation of the HPV vaccine at a national scale in Mozambique.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Awareness and acceptability</subject><subject>Cervical cancer</subject><subject>Cervix cancer</subject><subject>Child</subject><subject>Cross-Sectional Studies</subject><subject>Càncer de coll uterí</subject><subject>Female</subject><subject>Health Education - statistics &amp; numerical data</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunization Programs</subject><subject>Mozambique</subject><subject>Papillomaviridae - isolation &amp; purification</subject><subject>Papillomavirus Infections - prevention &amp; control</subject><subject>Papillomavirus Vaccines - administration &amp; dosage</subject><subject>Papillomaviruses</subject><subject>Papil·lomavirus</subject><subject>Patient Acceptance of Health Care</subject><subject>Surveys and Questionnaires</subject><subject>Uterine Cervical Neoplasms - prevention &amp; control</subject><subject>Uterine Cervical Neoplasms - virology</subject><subject>Vaccination - statistics &amp; numerical data</subject><subject>Vaccine</subject><subject>Young Adult</subject><issn>2405-8521</issn><issn>2405-8521</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kk1v3CAQhq2qVROl-QG9VBx72S1gwLYqVYqifkRK1UvuaIDxhsiGLdiO0l9fdjddbS49IL7eeYZ5map6z-iaUaY-Pay3S1pzyto1FWtKxavqnAsqV63k7PXJ-qy6zPmBUspkLTsm31ZnvFNKipqeV09Xj5AwYM4k9sRiWryFgVgIZU0gOPLoh8GHzV4yRWKQLGCtDzChI7ABH_JE7ucRAtnCtojjCItPcyY-kJ_xD4ymIAMBFwfMFsNENj4N-V31poch4-XzfFHdfft6d_1jdfvr-8311e3KStlNKy462zpJlZNCCGYMNLYp1fYGlOxbrgw10AnObI-mN5Q7J2xbI-WGC4T6oro5YF2EB71NfoT0pCN4vT-IaaMhTd4OqAUoI5u2daoWgrfUuFZiSdwhY05JVVhfDqztbEZ0u1oSDC-gL2-Cv9ebuGhFhVKtKAB2ANg8W52weGxh2gceN7vBacN1TRuldkk_PidN8feMedKjLzYOAwSMcy5a3tAiZM0JPsWcE_bHpzGqd02jiwNL0rum0VToYmOJ-XBa0zHiX4sUweeDAMsnLR6TztZjaQ_ny5unYqP_D_4v8OfVAA</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Bardají, Azucena</creator><creator>Mindu, Carolina</creator><creator>Augusto, Orvalho J.</creator><creator>Casellas, Aina</creator><creator>Cambaco, Olga</creator><creator>Simbine, Egas</creator><creator>Matsinhe, Graça</creator><creator>Macete, Eusébio</creator><creator>Menéndez, Clara</creator><creator>Sevene, Esperança</creator><creator>Munguambe, Khátia</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>XX2</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20180601</creationdate><title>Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls</title><author>Bardají, Azucena ; Mindu, Carolina ; Augusto, Orvalho J. ; Casellas, Aina ; Cambaco, Olga ; Simbine, Egas ; Matsinhe, Graça ; Macete, Eusébio ; Menéndez, Clara ; Sevene, Esperança ; Munguambe, Khátia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c559t-249c8d506d54441bba7c7004fba65f826b0ba9421cfebfb02dd4c83e02b24ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Awareness and acceptability</topic><topic>Cervical cancer</topic><topic>Cervix cancer</topic><topic>Child</topic><topic>Cross-Sectional Studies</topic><topic>Càncer de coll uterí</topic><topic>Female</topic><topic>Health Education - statistics &amp; numerical data</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunization Programs</topic><topic>Mozambique</topic><topic>Papillomaviridae - isolation &amp; purification</topic><topic>Papillomavirus Infections - prevention &amp; control</topic><topic>Papillomavirus Vaccines - administration &amp; dosage</topic><topic>Papillomaviruses</topic><topic>Papil·lomavirus</topic><topic>Patient Acceptance of Health Care</topic><topic>Surveys and Questionnaires</topic><topic>Uterine Cervical Neoplasms - prevention &amp; control</topic><topic>Uterine Cervical Neoplasms - virology</topic><topic>Vaccination - statistics &amp; numerical data</topic><topic>Vaccine</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Bardají, Azucena</creatorcontrib><creatorcontrib>Mindu, Carolina</creatorcontrib><creatorcontrib>Augusto, Orvalho J.</creatorcontrib><creatorcontrib>Casellas, Aina</creatorcontrib><creatorcontrib>Cambaco, Olga</creatorcontrib><creatorcontrib>Simbine, Egas</creatorcontrib><creatorcontrib>Matsinhe, Graça</creatorcontrib><creatorcontrib>Macete, Eusébio</creatorcontrib><creatorcontrib>Menéndez, Clara</creatorcontrib><creatorcontrib>Sevene, Esperança</creatorcontrib><creatorcontrib>Munguambe, Khátia</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Recercat</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Papillomavirus research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bardají, Azucena</au><au>Mindu, Carolina</au><au>Augusto, Orvalho J.</au><au>Casellas, Aina</au><au>Cambaco, Olga</au><au>Simbine, Egas</au><au>Matsinhe, Graça</au><au>Macete, Eusébio</au><au>Menéndez, Clara</au><au>Sevene, Esperança</au><au>Munguambe, Khátia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls</atitle><jtitle>Papillomavirus research</jtitle><addtitle>Papillomavirus Res</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>5</volume><spage>156</spage><epage>162</epage><pages>156-162</pages><issn>2405-8521</issn><eissn>2405-8521</eissn><abstract>Sub-Saharan Africa concentrates the largest burden of cervical cancer worldwide. The introduction of the HPV vaccination in this region is urgent and strategic to meet global health targets. This was a cross-sectional study conducted in Mozambique prior to the first round of the HPV vaccine demonstration programme. It targeted girls aged 10–19 years old identified from schools and households. Face-to-face structured interviews were conducted. A total of 1147 adolescents were enrolled in three selected districts of the country. Most girls [84% (967/1147)] had heard of cervical cancer, while 76% believed that cervical cancer could be prevented. However only 33% (373/1144) of girls recognized having ever heard of HPV. When girls were asked whether they would accept to be vaccinated if a vaccine was available in Mozambique, 91% (1025/1130) answered positively. Girls from the HPV demonstration districts showed higher awareness on HPV and cervical cancer, and willingness to be vaccinated. This study anticipates high acceptability of the HPV vaccine in Mozambique and high awareness about cervical cancer, despite low HPV knowledge. These results highlight that targeted health education programmes are critical for acceptance of new tools, and are encouraging for the reduction of cervical cancer related mortality and morbidity in Mozambique. •Cervical cancer incidence rates in Mozambique are among the highest in the world.•Introduction of HPV vaccination in Mozambique is an urgent and necessary strategy to meet global targets on women´s health.•The awareness on cervical cancer, and anticipated acceptance of HPV vaccination was assessed in Mozambican adolescent girls.•The study anticipates high acceptability of HPV vaccine and adequate awareness about cervical cancer.•These results are timely in the context towards the implementation of the HPV vaccine at a national scale in Mozambique.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>29665430</pmid><doi>10.1016/j.pvr.2018.04.004</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2405-8521
ispartof Papillomavirus research, 2018-06, Vol.5, p.156-162
issn 2405-8521
2405-8521
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4a6b5788d6344280bd85e06d9e11d656
source ScienceDirect (Online service); PubMed Central
subjects Adolescent
Adult
Awareness and acceptability
Cervical cancer
Cervix cancer
Child
Cross-Sectional Studies
Càncer de coll uterí
Female
Health Education - statistics & numerical data
Health Knowledge, Attitudes, Practice
Human papillomavirus
Humans
Immunization Programs
Mozambique
Papillomaviridae - isolation & purification
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines - administration & dosage
Papillomaviruses
Papil·lomavirus
Patient Acceptance of Health Care
Surveys and Questionnaires
Uterine Cervical Neoplasms - prevention & control
Uterine Cervical Neoplasms - virology
Vaccination - statistics & numerical data
Vaccine
Young Adult
title Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T15%3A22%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Awareness%20of%20cervical%20cancer%20and%20willingness%20to%20be%20vaccinated%20against%20human%20papillomavirus%20in%20Mozambican%20adolescent%20girls&rft.jtitle=Papillomavirus%20research&rft.au=Bardaj%C3%AD,%20Azucena&rft.date=2018-06-01&rft.volume=5&rft.spage=156&rft.epage=162&rft.pages=156-162&rft.issn=2405-8521&rft.eissn=2405-8521&rft_id=info:doi/10.1016/j.pvr.2018.04.004&rft_dat=%3Cproquest_doaj_%3E2027066617%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c559t-249c8d506d54441bba7c7004fba65f826b0ba9421cfebfb02dd4c83e02b24ea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2027066617&rft_id=info:pmid/29665430&rfr_iscdi=true